Relmada Therapeutics, Inc. (RLMD)
7.01
+0.26
(+3.85%)
USD |
NASDAQ |
Apr 08, 16:00
7.01
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics EPS Diluted (Quarterly) : -0.2911 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| Theravance Biopharma, Inc. | 1.150 |
| Avalo Therapeutics, Inc. | -0.7411 |
| AN2 Therapeutics, Inc. | -0.2869 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.87M |
| Total Expenses (Quarterly) | 19.87M |
| Enterprise Value | 642.27M |
| Earnings Yield | -20.19% |
| Normalized Earnings Yield | -20.28 |